US IPOs and Secondary Offerings, IPO Boutique

IPO Boutique

For more than 20 years, we have been providing research, analysis, commentary and ratings on US Equity Capital Markets to institutional investors (US IPOs and Secondary Offerings). Our vast network of contacts across the Equity Capital Markets and attention-to-detail sets us apart from our competitors.

Since 2012, we have achieved a successful hit rating on 89% of Buy-rated IPOs. The collective “Buy” ratings averaged a first trade of 16.3% above issue.Our Neutral Rated Deals averaged just 2% above the issue price at first trade.

Our written research includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

In addition, we provide a high-touch premium desk access which includes analyst access, as well as real time insights on US IPOs as well as secondary offerings.

US IPOs and Secondary Offerings

Exzeo Group, Inc. (XZO): Insurance Technology Platform Sets Terms for IPO; Seeking $2.0b Valuation

Exzeo Group, Inc. (XZO): Peeking at the IPO Prospectus of an Insurance Technology Platform Company

Exzeo Group, Inc. (XZO): Profitable HCI Spinoff Insurtech Drawing Interest from IPO Investors

IPOs and Secondary Offerings

Equity Capital Markets

<ul>
<li>Exzeo priced mid-range at $21.00 and traded flat, signaling a disciplined and stable market entrance.</li>
<li>Profitable, zero-debt insurtech spin-off from HCI boasting 50%+ EBITDA margins and $195M ARR.</li>
<li>Expanding beyond 13 states into major markets; poised for sustainable, high-margin growth under proven leadership.</li>
</ul>


Exzeo priced mid-range at $21.00 and traded flat, signaling a disciplined and stable market entrance.
Profitable, zero-debt insurtech spin-off from HCI boasting 50%+ EBITDA margins and $195M ARR.
Expanding beyond 13 states into major markets; poised for sustainable, high-margin growth under proven leadership.


Exzeo Group Inc. (XZO): IPO Opens Flat for the HCI Spin-Off Insurtech